Cargando…

First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid

OBJECTIVE: This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first‐line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy. METHODS: In this retrospective observational study, a competing risks model was used to estimate...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meer, Pim B., Dirven, Linda, Fiocco, Marta, Vos, Maaike J., Kouwenhoven, Mathilde C. M., van den Bent, Martin J., Taphoorn, Martin J. B., Koekkoek, Johan A. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251728/ https://www.ncbi.nlm.nih.gov/pubmed/33735464 http://dx.doi.org/10.1111/epi.16880

Ejemplares similares

The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide
por: van Opijnen, Mark P., et al.
Publicado: (2021)

Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020)

First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)

Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review
por: de Bruin, Marjolein E, et al.
Publicado: (2021)

Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study
por: van der Meer, Pim B., et al.
Publicado: (2022)

Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
por: van der Meer, Pim B., et al.
Publicado: (2023)

Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO members
por: van der Meer, Pim B, et al.
Publicado: (2021)

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study
por: Koekkoek, Johan A F, et al.
Publicado: (2014)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Management of epilepsy in brain tumor patients
por: van der Meer, Pim B., et al.
Publicado: (2022)

Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

The Impact of the Timing of Health-Related Quality of Life Assessments on the Actual Results in Glioma Patients: A Randomized Prospective Study
por: Peeters, Marthe C.M., et al.
Publicado: (2020)

Analyses of seizure responses supportive of a novel trial design to assess efficacy of antiepileptic drugs in infants and young children with epilepsy: Post hoc analyses of pediatric levetiracetam and lacosamide trials
por: Johnson, Martin E., et al.
Publicado: (2021)

Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
por: Zhang, Qirui, et al.
Publicado: (2018)

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015)

Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy
por: Silvennoinen, Katri, et al.
Publicado: (2019)

Behavioral disinhibition and antiepileptic treatment in childhood epilepsy: A retrospective cohort study
por: van Tuijl, Diana C., et al.
Publicado: (2017)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?
por: Hegazy, Yassmin, et al.
Publicado: (2023)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy
por: Huber‐Mollema, Yfke, et al.
Publicado: (2019)

Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014)

Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
por: Kuo, Cheng-Yen, et al.
Publicado: (2020)

Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome
por: Kurishima, Akira, et al.
Publicado: (2021)

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019)

Advance care planning in glioblastoma patients: development of a disease-specific ACP program
por: Fritz, Lara, et al.
Publicado: (2019)

Additional Antiepileptic Mechanisms of Levetiracetam in Lithium-Pilocarpine Treated Rats
por: Al-Shorbagy, Muhammad Y., et al.
Publicado: (2013)

Chronotolerance study of the antiepileptic drug valproic acid in mice
por: Ben-Cherif, Wafa, et al.
Publicado: (2012)

Levetiracetam in the treatment of epilepsy
por: Abou-Khalil, Bassel
Publicado: (2008)

Prediagnostic presentations of glioma in primary care: a case–control study
por: Peeters, Marthe CM, et al.
Publicado: (2019)

The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice
por: Smucny, Jason, et al.
Publicado: (2015)

Brivaracetam substituting other antiepileptic treatments: Results of a retrospective study in German epilepsy centers
por: Lerche, Holger, et al.
Publicado: (2020)

Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
por: Brodie, Martin J., et al.
Publicado: (2016)

Levetiracetam in the treatment of childhood epilepsy
por: Wheless, James W
Publicado: (2007)

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review
por: Coomans, Marijke B., et al.
Publicado: (2020)

The potential antiepileptic activity of astaxanthin in epileptic rats treated with valproic acid
por: Ata Yaseen Abdulqader, Yussra, et al.
Publicado: (2021)

Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022)

Mechanisms of Levetiracetam in the Control of Status Epilepticus and Epilepsy
por: Deshpande, Laxmikant S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1tvueruocklmfp1sl1vc5jtolt